Human Milk Oligosaccharides (HMO) Market
The Human Milk Oligosaccharides (HMO) market consists of bioactive carbohydrates, naturally found in human breast milk, that are produced for use as ingredients. Primary customers are manufacturers in the infant formula, functional food, and dietary supplement industries. Key growth drivers include rising consumer awareness of HMO health benefits for gut and immune support, increasing demand for enriched infant formulas, and technological advancements in fermentation and synthetic biology that are making production more accessible and cost-effective.
CAGR
22.6%
Compound Annual Growth Rate
Current Value
$360.0M
Estimated 2026
Projected Value
$1.82B
By 2034